Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway

Oncogene

Volumn 24, Issue 48, 2005, Pages 7238-7247

  Zhang, Zhuo ^a   Wang, Hui ^a,b   Li, Mao ^a   Rayburn, Elizabeth R ^a   Agrawal, Sudhir ^c   Zhang, Ruiwen ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c HYBRIDON INC   (United States)

Author keywords

E2F1; MDM2; Protein protein interaction; Ubiquitination

Indexed keywords

PROTEIN MDM2; PROTEIN P53; TRANSCRIPTION FACTOR E2F1; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; UBIQUITINATION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; COS CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; E2F1 TRANSCRIPTION FACTOR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HALF-LIFE; HUMANS; MALE; MICROSCOPY, CONFOCAL; OLIGONUCLEOTIDES, ANTISENSE; PRECIPITIN TESTS; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MDM2; UBIQUITIN; UP-REGULATION;

ANIMALIA;

EID: 27944478688     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208814     Document Type: Article

References (58)

1. Arakawa Y, Kajino K, Kano S, Tobita H, Hayashi J, Yasen M, Moriyama M, Arakawa Y and Hino O. (2004). Biochem. Biophys. Res. Commun., 322, 297-302.
2. Bardos JI, Chau NM and Ashcroft M. (2004). Mol. Cell. Biol., 24, 2905-2914.
3. Bartel F, Harris LC, Wurl P and Taubert H. (2004). Mol. Cancer Res., 2, 29-35.
4. Baudino TA, Maclean KH, Brennan J, Parganas E, Yang C, Aslanian A, Lees JA, Sherr CJ, Roussel MF and Cleveland JL. (2003). Mol. Cell, 11, 905-914.
5. Bell LA and Ryan KM. (2004). Cell Death Differ., 11, 137-142.
6. Bond GL, Hu W and Levine AJ. (2005). Curr. Cancer Drug Targets, 5, 3-8.
7. Campanero MR and Flemington EK. (1997). Proc. Natl. Acad. Sci. USA, 94, 2221-2226.
8. Chen J, Marechal V and Levine AJ. (1993). Mol. Cell. Biol., 13, 4107-4114.
9. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF and Levine AJ. (1994). Cancer Res., 54, 794-799.
10. Datta A, Nag A and Raychaudhuri P. (2002). Mol. Cell. Biol., 22, 8398-8408.
11. Deb SP. (2003). Mol. Cancer Res., 1, 1009-1016.
12. Fakharzadeh SS, Trusko SP and George DL. (1991). EMBO J., 10, 1565-1569.
13. Freedman DA and Levine AJ. (1998). Mol. Cell. Biol., 18, 7288-7293.
14. Fuchs SY, Adler V, Buschmann T, Wu X and Ronai Z. (1998). Oncogene, 17, 2543-2547.
15. Girnita L, Girnita A and Larsson O. (2003). Proc. Natl. Acad. Sci. USA, 100, 8247-8252.
16. Gorgoulis VG, Zacharatos P, Mariatos G, Kotsinas A, Bouda M, Kletsas D, Asimacopoulos PJ, Agnantis N, Kittas C and Papavassiliou AG. (2002). J. Pathol., 198, 142-156.
17. Hsieh JK, Chan FS, O'Connor DJ, Mittnacht S, Zhong S and Lu X. (1999). Mol. Cell, 3, 181-193.
18. Imai MA, Oda Y, Oda M, Nakanishi I and Kawahara E. (2004). J. Cancer Res. Clin. Oncol., 130, 320-326.
19. Iwakuma T and Lozano G. (2003). Mol. Cancer Res., 1, 993-1000.
20. Jiang Y, Saavedra HI, Holloway MP, Leone G and Altura RA. (2004). J. Biol. Chem., 279, 40511-40520.
21. Jin Y, Lee H, Zeng SX, Dai MS and Lu H. (2003). EMBO J., 22, 6365-6377.
22. Jones SN, Roe AE, Donehower LA and Bradley A. (1995). Nature, 378, 206-208.
23. Kinyamu HK and Archer TK. (2003). Mol. Cell. Biol., 23, 5867-5881.
24. Kovesdi I, Reichel R and Nevins JR. (1986). Cell, 45, 219-228.
25. La Thangue NB. (2003). Nat. Cell Biol., 5, 587-589.
26. Lee JS, Chu IS, Mikaelyan A, Calvisi DF, Heo J, Reddy JK and Thorgeirsson SS. (2004). Nat. Genet., 36, 1306-1311.
27. Li M, Brooks CL, Wu-Baer F, Chen D, Baer R and Gu W. (2003). Science, 302, 1972-1975.
28. Liang H, Atkins H, Abdel-Fattah R, Jones SN and Lunec J. (2004). Gene, 338, 217-223.
29. Lin HK, Wang L, Hu YC, Altuwaijri S and Chang C. (2002). EMBO J., 21, 4037-4048.
30. Lin WC, Lin FT and Nevins JR. (2001). Genes Dev., 15, 1833-1844.
31. Logan N, Delavaine L, Graham A, Reilly C, Wilson J, Brummelkamp TR, Hijmans EM, Bernards R and La Thangue NB. (2004). Oncogene, 23, 5138-5150.
32. Louie MC, Zou JX, Rabinovich A and Chen HW. (2004). Mol. Cell. Biol., 24, 5157-5171.
33. Marti A, Wirbelauer C, Scheffner M and Krek W. (1999). Nat. Cell Biol., 1, 14-19.
34. Martin K, Tronche D, Hagemeier C, Sorensen TS, La Thangue NB and Kouzarides T. (1995). Nature, 375, 691-694.
35. Meek DW and Knippschild U. (2003). Mol. Cancer Res., 1, 1017-1026.
36. Minsky N and Oren M. (2004). Mol. Cell, 16, 631-639.
37. Momand J, Zambetti GP, Olson DC, George D and Levine AJ. (1992). Cell, 69, 1237-1245.
38. Mundle SD and Saberwal G. (2003). FASEB J., 17, 569-574.
39. Onda M, Nagai H, Yoshida A, Miyamoto S, Asaka S, Akaishi J, Takatsu K, Nagahama M, Ito K, Shimizu K and Emi M. (2004). J. Hum. Genet., 49, 312-318.
40. Rayburn ER, Zhang RW, He J and Wang H. (2005). Curr. Cancer Drug Targets, 5, 27-42.
41. Stanelle J, Tu-Rapp H and Putzer BM. (2005). Cell Death Differ., 2, 347-357.
42. Steinman HA, Burstein E, Lengner C, Gosselin J, Pihan G, Duckett CS and Jones SN. (2004). J. Biol. Chem., 279, 4877-4886.
43. Sun P, Dong P, Dai K, Hannon GJ and Beach D. (1998). Science, 282, 2270-2272.
44. Trimarchi JM and Lees JA. (2002). Nat. Rev. Mol. Cell Biol., 3, 11-20.
45. Vargas DA, Takahashi S and Ronai Z. (2003). Adv. Cancer Res., 89, 1-34.
46. Wang H, Nan L, Yu D, Agrawal S and Zhang R. (2001). Clin. Cancer Rex., 7, 3613-3624.
47. Wang H, Nan L, Yu D, Lindsey JR, Agrawal S and Zhang R. (2002). Mol. Med., 8, 185-198.
48. Wang H, Oliver P, Zhang Z, Agrawal S and Zhang R. (2003a). Ann. NY Acad. Sci., 1002, 217-235.
49. Wang H, Yu D, Agrawal S and Zhang R. (2003b). Prostate, 54, 194-205.
50. Wang H, Zeng X, Oliver P, Le LP, Chen J, Chen L, Zhou W, Agrawal S and Zhang R. (1999). Int. J. Oncol., 15, 653-660.
51. Wikonkal NM, Remenyik E, Knezevic D, Zhang W, Liu M, Zhao H, Berton TR, Johnson DG and Brash DE. (2003). Nat. Cell Biol., 5, 655-660.
52. Yamazaki K, Yajima T, Nagao T, Shinkawa H, Kondo F, Hanami K, Asoh A, Sugano I and Ishida Y. (2003). Pathol. Res. Pract., 199, 23-28.
53. Zhang R and Wang H. (2000). Curr. Pharm. Des., 6, 393-416.
54. Zhang R, Wang H and Agrawal S. (2005). Curr. Cancer Drug Targets, 5, 43-50.
55. Zhang Z, Li M, Wang H, Agrawal S and Zhang R. (2003). Proc. Natl. Acad. Sci. USA, 100, 11636-11641.
56. Zhang Z, Wang H, Li M, Agrawal S, Chen X and Zhang R. (2004a). J. Biol. Chem., 279, 16000-16006.
57. Zhang Z, Wang H, Prasad G, Li M, Yu D, Bonner JA, Agrawal S and Zhang R. (2004b). Clin. Cancer Res., 10, 1263-1273.
58. Zhang Z and Zhang R. (2005). Curr. Cancer Drug Targets, 5, 9-20.